Related Experiment Video
Updated: Aug 23, 2025
A Seminiferous Tubule Squash Technique for the Cytological Analysis of Spermatogenesis Using the Mouse Model
Published on: February 6, 2018
Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis
Kirill E Medvedev1, Anna V Savelyeva2, Kenneth S Chen3,4
1Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Objective:
Testicular germ cell tumors (TGCT) are the most common solid malignancy in adolescent and young men, with a rising incidence over the past 20 years. Overall, TGCTs are second in terms of the average life years lost per person dying of cancer, and clinical therapeutics without adverse long-term side effects are lacking. Platinum-based regimens for TGCTs have heterogeneous outcomes even within the same histotype that frequently leads to under- and over-treatment. Understanding of molecular differences that lead to diverse outcomes of TGCT patients may improve current treatment approaches. Seminoma is the most common subtype of TGCTs, which can either be pure or present in combination with other histotypes.
Methods:
Here we conducted a computational study of 64 pure seminoma samples from The Cancer Genome Atlas, applied consensus clustering approach to their transcriptomic data and revealed 2 clinically relevant seminoma subtypes: seminoma subtype 1 and 2.
Results:
Our analysis identified significant differences in pluripotency stage, activity of double stranded DNA breaks repair mechanisms, rates of loss of heterozygosity, and expression of lncRNA responsible for cisplatin resistance between the subtypes. Seminoma subtype 1 is characterized by higher pluripotency state, while subtype 2 showed attributes of reprograming into non-seminomatous TGCT. The seminoma subtypes we identified may provide a molecular underpinning for variable responses to chemotherapy and radiation.
Conclusion:
Translating our findings into clinical care may help improve risk stratification of seminoma, decrease overtreatment rates, and increase long-term quality of life for TGCT survivors.
Insights
Testicular germ cell tumors (TGCT) are common in young men. This study identified two seminoma subtypes with distinct molecular features, potentially improving risk stratification and treatment for TGCT patients.
Area of Science:
- Oncology
- Genomics
- Cancer Research
Background:
- Testicular germ cell tumors (TGCT) are the most common solid malignancy in adolescent and young men.
- Current platinum-based chemotherapy for TGCTs yields heterogeneous outcomes, leading to undertreatment and overtreatment.
- Understanding molecular differences in TGCTs is crucial for improving treatment strategies and patient quality of life.
Purpose of the Study:
- To computationally analyze transcriptomic data from pure seminoma samples.
- To identify distinct molecular subtypes of seminoma.
- To explore the clinical relevance of identified seminoma subtypes for treatment stratification.
Main Methods:
- Utilized consensus clustering on transcriptomic data from 64 pure seminoma samples from The Cancer Genome Atlas.
- Analyzed differences in pluripotency, DNA repair mechanisms, loss of heterozygosity, and lncRNA expression between subtypes.
Main Results:
- Identified two clinically relevant seminoma subtypes: subtype 1 and subtype 2.
- Subtype 1 exhibits a higher pluripotency state.
- Subtype 2 displays characteristics of reprogramming into non-seminomatous TGCT, with differences in DNA repair and cisplatin resistance-related lncRNA expression.
Conclusions:
- The identified seminoma subtypes offer a molecular basis for variable responses to chemotherapy and radiation.
- Findings may enhance risk stratification for seminoma patients.
- Potential to reduce overtreatment and improve long-term quality of life for TGCT survivors.
